Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tvardi Therapeutics (TVRD) Change in Cash: 2013-2017

Historic Change in Cash for Tvardi Therapeutics (TVRD) over the last 5 years, with Dec 2017 value amounting to -$3.1 million.

  • Tvardi Therapeutics' Change in Cash fell 141.75% to -$3.1 million in Q4 2017 from the same period last year, while for Dec 2017 it was -$3.4 million, marking a year-over-year decrease of 51.96%. This contributed to the annual value of -$15.8 million for FY2024, which is 50.77% down from last year.
  • Per Tvardi Therapeutics' latest filing, its Change in Cash stood at -$3.1 million for Q4 2017, which was down 230.64% from $2.4 million recorded in Q3 2017.
  • Tvardi Therapeutics' Change in Cash's 5-year high stood at $67.9 million during Q3 2015, with a 5-year trough of -$96.0 million in Q4 2015.
  • Moreover, its 3-year median value for Change in Cash was -$3.7 million (2015), whereas its average is -$3.6 million.
  • In the last 5 years, Tvardi Therapeutics' Change in Cash spiked by 12,905.85% in 2014 and then tumbled by 1,575.65% in 2015.
  • Tvardi Therapeutics' Change in Cash (Quarterly) stood at -$5.4 million in 2013, then fell by 6.58% to -$5.7 million in 2014, then tumbled by 1,575.65% to -$96.0 million in 2015, then spiked by 107.74% to $7.4 million in 2016, then plummeted by 141.75% to -$3.1 million in 2017.
  • Its Change in Cash was -$3.1 million in Q4 2017, compared to $2.4 million in Q3 2017 and $4.1 million in Q2 2017.